Volume 141, Issue 1, Pages e2 (July 2011)

Slides:



Advertisements
Similar presentations
Volume 94, Issue 2, Pages (March 2014)
Advertisements

Volume 132, Issue 3, Pages (March 2007)
Volume 144, Issue 3, Pages e1 (March 2013)
Volume 34, Issue 3, Pages (March 2011)
Volume 129, Issue 1, Pages (July 2005)
Volume 136, Issue 4, Pages e3 (April 2009)
Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion by Yenan T. Bryceson, Michael E. March, Hans-Gustaf.
Volume 133, Issue 4, Pages (October 2007)
Volume 137, Issue 3, Pages e7 (September 2009)
A Controlled Study of Colonic Immune Activity and β7+ Blood T Lymphocytes in Patients With Irritable Bowel Syndrome  Lena Öhman, Stefan Isaksson, Anna.
Volume 143, Issue 4, Pages e9 (October 2012)
Volume 143, Issue 5, Pages e4 (November 2012)
Volume 138, Issue 5, Pages e2 (May 2010)
Volume 132, Issue 7, Pages (June 2007)
Volume 132, Issue 7, Pages (June 2007)
Myeloid-Derived Suppressor Cells in Psoriasis Are an Expanded Population Exhibiting Diverse T-Cell–Suppressor Mechanisms  Lauren Y. Cao, Jin-Sung Chung,
Characterization of Interleukin-17–Producing Regulatory T Cells in Inflamed Intestinal Mucosa From Patients With Inflammatory Bowel Diseases  Zaruhi Hovhannisyan,
Volume 147, Issue 1, Pages e7 (July 2014)
Volume 142, Issue 2, Pages e2 (February 2012)
Volume 5, Issue 4, Pages (April 2009)
Volume 138, Issue 4, Pages (April 2010)
Volume 141, Issue 3, Pages (September 2011)
Volume 132, Issue 7, Pages (June 2007)
Volume 138, Issue 3, Pages (March 2010)
Reconstitution of Natural Killer Cells in HLA-Matched HSCT after Reduced-Intensity Conditioning: Impact on Clinical Outcome  Caroline Pical-Izard, Roberto.
Volume 153, Issue 5, Pages e2 (November 2017)
Volume 18, Issue 5, Pages (May 2003)
Volume 140, Issue 7, Pages (June 2011)
Volume 134, Issue 7, Pages e2 (June 2008)
Volume 140, Issue 1, Pages e3 (January 2011)
Volume 137, Issue 5, Pages (November 2009)
Volume 134, Issue 4, Pages e2 (April 2008)
Kathleen R. Bartemes, BA, Gail M. Kephart, BS, Stephanie J
Volume 140, Issue 5, Pages e3 (May 2011)
Volume 139, Issue 3, Pages e3 (September 2010)
Volume 141, Issue 1, Pages e1 (July 2011)
Volume 140, Issue 2, Pages e4 (February 2011)
Volume 31, Issue 2, Pages (August 2009)
Volume 141, Issue 5, Pages e2 (November 2011)
Volume 138, Issue 2, Pages e4 (February 2010)
Volume 144, Issue 3, Pages e1 (March 2013)
Human mast cells drive memory CD4+ T cells toward an inflammatory IL-22+ phenotype  Nicolas Gaudenzio, PhD, Camille Laurent, MD, Salvatore Valitutti,
Volume 135, Issue 1, Pages (July 2008)
Volume 134, Issue 7, Pages e2 (June 2008)
Volume 81, Issue 4, Pages (February 2012)
Volume 135, Issue 2, Pages e2 (August 2008)
Volume 24, Issue 9, Pages (September 2016)
Volume 138, Issue 1, Pages (January 2010)
Skint-1 Identifies a Common Molecular Mechanism for the Development of Interferon-γ- Secreting versus Interleukin-17-Secreting γδ T Cells  Gleb Turchinovich,
Mammalian target of rapamycin inhibition counterbalances the inflammatory status of immune cells in patients with chronic granulomatous disease  Aurélie.
Volume 36, Issue 6, Pages (June 2012)
Volume 135, Issue 3, Pages (September 2008)
Volume 34, Issue 3, Pages (March 2011)
Volume 32, Issue 1, Pages (January 2010)
Volume 17, Issue 2, Pages (February 2009)
Volume 36, Issue 4, Pages (April 2012)
Dysregulation of Lymphocyte Interleukin-12 Receptor Expression in Sézary Syndrome  Mohamed H. Zaki, Ryan B. Shane, Yuemei Geng, Louise C. Showe, Suzanne.
Josée Lamoureux, PhD, Jana Stankova, PhD, Marek Rola-Pleszczynski, MD 
Volume 33, Issue 5, Pages (November 2010)
Volume 37, Issue 6, Pages (December 2012)
Volume 128, Issue 3, Pages (March 2005)
Sibylle von Vietinghoff, Hui Ouyang, Klaus Ley  Kidney International 
Volume 32, Issue 6, Pages (June 2010)
Volume 136, Issue 7, Pages (June 2009)
Volume 131, Issue 6, Pages (December 2006)
Volume 132, Issue 7, Pages (June 2007)
IL-10–producing monocytes differentiate to alternatively activated macrophages and are increased in atopic patients  Antje Prasse, MD, Martin Germann,
Volume 142, Issue 7, Pages e6 (June 2012)
Volume 126, Issue 5, Pages (May 2004)
Volume 138, Issue 2, Pages e4 (February 2010)
Presentation transcript:

Volume 141, Issue 1, Pages 217-226.e2 (July 2011) Activation of the Receptor NKG2D Leads to Production of Th17 Cytokines in CD4+ T Cells of Patients With Crohn's Disease  Benjamin Pariente, Iulia Mocan, Matthieu Camus, Charles–Antoine Dutertre, Julien Ettersperger, Pierre Cattan, Jean–Marc Gornet, Nicolas Dulphy, Dominique Charron, Marc Lémann, Antoine Toubert, Matthieu Allez  Gastroenterology  Volume 141, Issue 1, Pages 217-226.e2 (July 2011) DOI: 10.1053/j.gastro.2011.03.061 Copyright © 2011 AGA Institute Terms and Conditions

Figure 1 CD4+NKG2D+ T cells are a major source of IL-17 in CD. (A–D) PBLs (n = 42) and LPLs (n = 16) were isolated from patients with active CD and stimulated with PMA/ionomycin. Intracellular staining for IL-17 was analyzed by flow cytometry on gated CD3+ CD4+, CD4+NKG2D+, and CD4+NKG2D− T-cell populations. Scattergrams show percentages of overall IL-17–positive cells among (A) LP and PB CD4+ T cells (n = 13), (B) LP CD4+NKG2D+ and CD4+NKG2D− T cells (n = 16), and (C) PB CD4+NKG2D+ and CD4+NKG2D− T cells (n = 42). Median values are indicated by a bar. *P < .05, **P < .005. (D and E) These figures represent flow cytometric analysis of IL-17 intracellular staining in (D) LP and (E) PB CD4+NKG2D+ (right dot plot) and CD4+NKG2D− (left dot plot) T cells in 2 patients. Plots are representative of (D) 16 and (E) 42 independent patients with CD. Isotype control antibody staining was used for gate settings. (F) LP mononuclear cells from patients with active CD (n = 4) were fluorescence-activated cell sorted for CD4−, CD4+NKG2D+, and CD4−NKG2D− T cells, and gene expression was profiled. RORC (white bars) and IL-17A (black bars) gene expression was assessed by Q-RT-PCR and normalized to CD3e RNA. *P < .05. Gastroenterology 2011 141, 217-226.e2DOI: (10.1053/j.gastro.2011.03.061) Copyright © 2011 AGA Institute Terms and Conditions

Figure 2 CD4+NKG2D+ T cells exhibit Th17 and NK markers. Flow cytometry analysis of CCR6, IL-23R, CD161, and NKG2D expression was performed on (A and B) LPLs (n = 12) and (C–E) PBLs (n = 26) isolated from patients with active CD. Scattergrams indicate percentages of (A) CCR6 and (B) IL-23R expression on CD3+ CD4+NKG2D+, CD4+NKG2D−, and CD8+NKG2D+ LP T-cell populations. (C) This figure represents flow cytometric analysis of IL-23R staining in PB CD4+NKG2D+ and CD4+NKG2D− T cells in one patient. The plot is representative of n = 26 independent CD patients. Isotype control antibody staining was used for gate settings. (D) Graphics indicate proportions of PB CD4+ T cells expressing CD161 in patients with CD (n = 26) as compared with patients with UC (n = 12) and HCs (n = 10). (E) Scattergrams indicate percentages of CD161-positive cells among CD3+ CD4+NKG2D+, CD4+NKG2D−, and CD8+NKG2D+ PB T-cell populations. Median values are indicated by a bar. *P < .05, **P < .005. Gastroenterology 2011 141, 217-226.e2DOI: (10.1053/j.gastro.2011.03.061) Copyright © 2011 AGA Institute Terms and Conditions

Figure 3 NKG2D expression identifies IL-17–producing cells. PBLs were stimulated with PMA/ionomycin before IL-17 intracellular staining. Analysis of IL-17 production was gated on CD4+ T cells. (A) This figure is representative of analysis performed in 10 patients with active CD. NKG2D and CD161 expression in IL-17–negative (left dot plot) and IL-17–positive (right dot plot) CD4+ T cells in one patient is shown. (B and C) Expressions of CD161 (gray bars) and NKG2D (black bars) on (B) CD4+IL-17− and (C) CD4+IL-17+ lymphocytes from 10 patients with CD are plotted. Gastroenterology 2011 141, 217-226.e2DOI: (10.1053/j.gastro.2011.03.061) Copyright © 2011 AGA Institute Terms and Conditions

Figure 4 NKG2D costimulation significantly enhances IL-17 secretion triggered by the TCR in CD4+ T cells. (A–D) PBLs isolated from 7 patients with CD were cultured in the presence of P815 cell lines transfected or not with MICA coated with an immunoglobulin G1 antibody (isotype) or with an anti-CD3 agonist antibody at 1 μg/mL concentration and/or with an anti-CD28 antibody at 5 μg/mL concentration. Analysis of (A) IL-17, (B) IFN-γ, and (C) TNF-α intracellular staining was gated on CD3+ CD4+ T cells. (D) Analysis of IL-17 intracellular staining was gated on CD3+ CD4+NKG2D+ T cells. Histograms represent percentage of CD4+ T cells expressing IL-17 under different stimulations. *P < .05, **P < .005. (E) In this experiment, PBLs of one patient were cultured in the presence of P815 cell lines transfected or not with ULBP2, coated with an IgG1 antibody (isotype) or with an anti-CD3 agonist antibody. IL-17 production versus IFN-γ and TNF-α production and CD107a expression were analyzed in gated CD3+CD4+ T cells. The dot plots are representative of 7 independent experiments. Gastroenterology 2011 141, 217-226.e2DOI: (10.1053/j.gastro.2011.03.061) Copyright © 2011 AGA Institute Terms and Conditions

Figure 5 IL-23 drives IL-17 secretion by CD4+NKG2D+ T cells. LP mononuclear cells isolated from 5 patients with CD were cultured with anti-CD2/anti-CD3/anti-CD28 activation beads and with the addition of IL15, IL-12, IL-1β, and/or IL-23 as indicated. After 3 days of culture, the cells were stimulated with PMA/ionomycin. Intracellular staining for IL-17 was analyzed by flow cytometry on gated CD3+ CD4+NKG2D+ and CD4+NKG2D− T-cell populations. Individual symbols represent individual patients with CD to visualize trends per patient. Horizontal bars represent mean values. *P < .05. Gastroenterology 2011 141, 217-226.e2DOI: (10.1053/j.gastro.2011.03.061) Copyright © 2011 AGA Institute Terms and Conditions

Figure 6 IL-17/IL-22– and IL-17/IFN-γ–producing cells are mainly found among CD4+NKG2D+ T cells. LP lymphocytes were stimulated with PMA/ionomycin before IL-17, IL-22, and IFN-γ intracellular staining. Analysis of IL-17/IL-22 and IL-17/IFN-γ production was assessed in CD3+ CD4+NKG2D+, CD4+NKG2D−, and CD8+NKG2D+ LP T cells. This figure is representative of analysis performed in 8 patients with active CD. Gastroenterology 2011 141, 217-226.e2DOI: (10.1053/j.gastro.2011.03.061) Copyright © 2011 AGA Institute Terms and Conditions

Supplementary Figure 1 IL-17 secretion by ex vivo PB CD4+ T cells from patients with CD, patients with UC, and HCs. PBLs were isolated from patients with CD (n = 42), patients with UC (n = 9), and HCs (n = 10) and stimulated with PMA/ionomycin. Intracellular staining for IL-17 was analyzed by flow cytometry on gated CD3+ CD4+ T cells. (A) Scattergrams show the percentages of overall IL-17–positive cells among PB CD4+ T cells. Median values are indicated by a bar. *P < .05, **P < .005. (B) This figure represents flow cytometric analysis of IL-17 intracellular staining in PB CD4+ T cells in one patient with CD (left dot plot), one patient with UC (middle dot plot), and one HC (right dot plot). Gates have been set regarding isotype control antibody staining. Gastroenterology 2011 141, 217-226.e2DOI: (10.1053/j.gastro.2011.03.061) Copyright © 2011 AGA Institute Terms and Conditions

Supplementary Figure 2 NKG2D expression by PB CD4+ T cells from patients with CD, patients with UC, and HCs. PB lymphocytes were isolated from patients with CD (n = 28), patients with UC (n = 12), and HCs (n = 10). NKG2D staining was analyzed by flow cytometry on gated CD3+ CD4+ T cells. Scattergrams show the percentages of overall NKG2D-positive cells among PB CD4+ T cells. Median values are indicated by a bar. *P < .05, **P < .005. Gastroenterology 2011 141, 217-226.e2DOI: (10.1053/j.gastro.2011.03.061) Copyright © 2011 AGA Institute Terms and Conditions

Supplementary Figure 3 IL-17 production under NKG2D stimulation through its different ligands expressed on the P815 cell line is different from patient to patient. PBLs isolated from patients with CD were cultured in the presence of P815 cell lines transfected or not with MICA, MICB, ULBP1, ULBP2, or ULBP3, coated with an immunoglobulin G1 antibody (isotype) or with an anti-CD3 agonist antibody at 1 μg/mL concentration. Analysis of IL-17 intracellular staining was gated on CD3+ CD4+ T cells. Histograms represent percentage of CD4+ T cells expressing IL-17 under stimulation through each ligand in 3 different patients. In each patient, IL-17 production was maximal under stimulation of both NKG2D and TCR when NKG2D was triggered by (A) MICA, (B) MICB, or (C) ULBP2 interaction. Gastroenterology 2011 141, 217-226.e2DOI: (10.1053/j.gastro.2011.03.061) Copyright © 2011 AGA Institute Terms and Conditions